Vitiligo is an acquired and progressive disorder manifested by the selective destruction of melanocytes in the skin. An extremely high level of hydrogen peroxide (H 2 O 2 ) in plasma as well as in lesional skin has been reported in vitiligo patients. High H 2 O 2 level has been suggested to be responsible for the disappearance of melanocytes in vitiligo. JNK and p38 MAPK are strongly induced by oxidative stress and related to neuron loss in neurodegenerative disorders. Minocycline, an antibiotic possessing antioxidant activity, is capable of attenuating oxidative stress-induced neurotoxicity. To investigate whether minocycline rescues melanocytes from H 2 O 2 -induced apoptosis, cultured mouse melanocytes (B10BR) were treated with H 2 O 2 in the presence or absence of minocycline. Our data showed that H 2 O 2 decreases cell viability in a concentration-dependent manner which is attenuated by minocycline. Also, H 2 O 2 treatment activates JNK and p38 MAPK, and executive caspase 3 in B10BR cells. Minocycline significantly inhibits H 2 O 2 -induced activation of JNK, p38 MAPK and caspase 3. Collectively, we concluded that minocycline protects melanocytes against H2O2-induced apoptosis in vitro. Its protective effect is associated with the inhibition of JNK and p38 MAPK. Our findings suggest that minocycline, a clinically well-tolerated, safe antibiotic, may be used to prevent melanocyte loss in the early stage of vitiligo.
Introduction
Vitiligo is an acquired pigmentary disorder characterized by well-circumscribed depigmented patches. Autoimmune, selfdestruction, neural, and genetic theories have been proposed for the pathogenesis of vitiligo. Although none of these theories is sufficient to explain the pathogenesis of the disease, reactive oxygen species may play an important role in the pathology of melanocyte damage (1) . There are several lines of evidence for the accumulation of hydrogen peroxide (H 2 O 2 ) in the epidermis of acute vitiligo patients, and the concentration is in the 10 -3 M range (2, 3) . Moreover, the level of H 2 O 2 has been reported to increase in the plasma and urine of vitiligo patients as well as in lesional skin. The increases mainly occur at the onset and progression phase, possibly contributing to the disappearance of melanocytes in vitiligo (4) (5) (6) . Thus it implies impaired antioxidant defense capacity in vitiligo.
The mechanism that accounts for apoptosis induced by H 2 O 2 in melanocytes is still under investigation. There is much evidence that suggests constant accumulation of H 2 O 2 leading to a cascade of impaired signals in active vitiligo (7) (8) (9) (10) (11) . Moreover, the calmodulin-regulated calcium homeostasis is altered by H 2 O 2 -mediated stress due to the loss of calcium binding on the protein (6) . JNK and p38 MAPK activation is reportedly involved in dopamine-induced melanocyte apoptosis (12) . However, mitogen-activated protein kinase (MAPK) signal transduction has still not been thoroughly studied in H 2 O 2 -induced apoptosis in melanocytes. Thus the current study was carried out to investigate whether MAPKs, especially JNK and p38 MAPK, contribute to melanocyte loss after H 2 O 2 treatment.
H 2 O 2 is a putative mediator of melanocyte death in vitiligo. Removal of H 2 O 2 by antioxidant has been proven to be beneficial to patients. Several reports suggested that a topical substitution with a UVB-activated pseudocatalase can successfully remove epidermal H 2 O 2 and achieve remarkable repigmentation in vitiligo (13, 14) . In contrast, other researchers found that topical pseudocatalase was not effective for vitiligo in an open, single-center study (15) . In such a case, resort to other drugs which could alleviate oxidative stress damage would be necessary. Such drugs might be used to treat vitiligo in clinics.
Minocycline possesses antioxidant activity and is capable of inhibiting both free radical production and lipid peroxidation in a concentration-dependent manner (16) (17) (18) . It has been reported that minocycline attenuates 6-hydroxydopamine-induced neurotoxicity in rat cerebellar granule neurons (19) and exerts protective effects against oxidative stress in the mouse brain (20) . However, whether minocycline can protect melanocytes, one kind of epidermal cell differentiated from neural crest cells, against apoptosis induced by H 2 O 2 , is still unknown.
Given the above, the purpose of the present study was to investigate the underlying molecular mechanism responsible for H 2 O 2 -induced apoptosis and whether minocycline exerts a protective effect on B10BR mouse melanocytes.
Materials and methods
Cell culture. As described previously (21) , spontaneously immortalized mouse melanocyte B10BR cell line (purchased from the Department of Dermatology, Yale University) was maintained in F10 medium (Sigma, St. Louis, MO) supplemented with a 7% horse serum (Hyclone, USA), 50 nM tetradecanoyl phorbol acetate (TPA, Sigma), penicillin/streptomycin (1:100, Sigma) and 4 mM L-glutamine, in a humid atmosphere incubator with 5% CO 2 at 37˚C. For Western blot analysis, cells were reseeded in 6-well plates at a density of 1x10 5 cells/ml with fresh complete culture medium. Morphological changes were observed under phase contrast microscopy. Unless otherwise indicated, cultures were grown to 70-80% confluence and then serum-starved overnight in F10 medium prior to treatment.
Antibodies and inhibitors.
Rabbit anti-phospho-JNK, rabbit anti-phospho-p38 and rabbit anti-caspase 3 were obtained from Cell Signaling Technology (Danvers, MA). Goat antirabbit IgG-HRP and goat anti-mouse IgG-HRP antibody were received from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal mouse anti-ß-actin, minocycline (Mino) and H 2 O 2 were obtained from Sigma. JNKi and SB 203580 were from Calbiochem (San Diego, CA).
MTT dye assay. Cell viability was assessed using the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide dye (MTT) assay (22) . The assay was performed according to the instructions of the manufacturer. Briefly, B10BR cells were cultured in 96-well plates, 20 μl of 5 mg/ml MTT labeling reagent was added to each well containing cells in 150 μl of medium, and the plate was incubated for 4 h in a humidified incubator at 37˚C to allow the MTT to be metabolized. The media were removed and cells were re-suspended in formazan (MTT metabolic product) in 200 μl dimethyl sulfoxide (DMSO). The plate was placed on a shaker for 5 min to thoroughly mix the formazan into the solvent. The absorbance of the samples was measured at a wavelength of 490 nm. The extent of MTT conversion in cells exposed to H 2 O 2 is expressed as a percentage of the control.
FACS analysis. Twenty-four hours after H 2 O 2 and minocycline treatment, both detached and attached cells were harvested and combined. Mild trypsinization was used to collect the attached cells. Cells were centrifuged at 200 x g for 5 min, washed twice with PBS, stained with FITC-conjugated annexin-V (BD Pharmingen) and propidium iodide (PI) for 30 min in the dark at room temperature, and subjected to two-color analysis using FACScalibur (Becton Dickinson, Mountain View, CA).
Western blot analysis. As reported previously (23) , cultured mouse melanocytes with and without treatment were washed with cold PBS and harvested by scraping into 150 μl of RIPA buffer. Cell lysates were incubated in 4˚C for 30 min. Proteins (20 μg) were denatured in 5X SDS-PAGE sample buffer for 5 min at 95˚C. The proteins were separated by 10% SDS-PAGE and transferred onto PVDF membrane (Millipore, Bedford, MA). Nonspecific binding was blocked with 10% dry milk in TBST for 1 h at room temperature. After blocking, membranes were incubated with specific antibodies in dilution buffer (2% BSA in TBS) overnight at 4˚C. The blots were incubated with horseradish peroxidase-conjugated antirabbit or anti-mouse IgG at appropriate dilutions and room temperature for 1 h. Antibody binding was detected using enhanced chemiluminescence (ECL) detection system (GE Biosciences, NJ) following manufacturer's instructions and visualized by autoradiography with Hyperfilm.
Melanin quantification. As previously reported (24), B10BR cells were seeded in 6-well culture plates and were treated with various concentrations of H 2 O 2 and minocycline for 24 h. Then cells were washed twice with PBS, detached with 0.25% Tripsin/EDTA. Cell pellets were disrupted in a lysis buffer (20 mM Tris, pH 7.5, 0.1% Triton X-100) on ice for 30 min. After centrifugation, the pellets were washed twice with 5% trichloroacetic acid, twice with a cold mixture of ethanol and ethyl ether (3:1), and once with cold ethyl ether. The dried pellets were dissolved in 0.85 N NaOH by boiling for 10 min, and the absorbance values were then measured at a wavelength of 405 nm. Amounts of melanin were calculated from the standard curves for synthetic melanin. Fig. 2A-D Minocycline inhibits the activation of p38 MAPK, JNK and caspase 3 induced by H 2 O 2 . The data above clearly demonstrate that p38 and JNK activation is involved in H 2 O 2 -induced apoptosis. However, whether this activation or other mechanisms are involved in the protective effects of minocycline against H 2 O 2 -induced apoptosis has not been studied. We therefore pretreated melanocytes with minocycline for 30 min before adding H 2 O 2 into medium and collected cells at 20 min after H 2 O 2 treatment. As shown in Fig. 3A and C, the phosphorylation of p38 and JNK is significantly inhibited, capase 3 activation is also blocked accordingly, as shown in Fig. 3E . The inhibitory effects of minocycline on the activation of p38, JNK and capase 3 are concentration-dependent. Treatment with SB203580 and JNKi, classic p38 and JNK activation inhibitors, not only blocks H 2 O 2 -induced p38 and JNK phosphorylation, but also blocks caspase 3 activation significantly, confirming the signal transduction pathways in H 2 O 2 -induced melanocyte apoptosis, shown in Fig. 3B and D-F. These results demonstrate that inhibition of p38 and JNK activation as well as an inhibitory role in caspase 3 activation is involved, at least in part, in the protective effects of minocycline against H 2 O 2 -induced apoptosis in melanocytes. concentrations of minocycline (10-100 μM) for 30 min before 250 μM H 2 O 2 was added. The MTT data showed that minocycline caused concentration-dependent protective effects on cell viability, as shown in Fig. 4A . p38 inhibitor, SB, or JNK inhibitor, JNKi, also showed the protective effects against H 2 O 2 -induced cell death (Fig. 4B) . The apoptosis rate was further quantified by flow cytometry and the data showed that minocycline protected against H 2 O 2 -induced cell death in a concentration-dependent manner, as shown in Fig.  4C . In addition, the melanocyte morphological changes induced by H 2 O 2 were reversed by pretreatment with minocycline (Fig. 4D) . The above data demonstrate that p38 and JNK were involved in the melanocyte apoptosis pathway. To further study whether inhibition of p38 and JNK phophorylation protects melanocytes against apoptosis, B10BR cells were pretreated with p38 inhibitor, SB, or JNK inhibitor, JNKi. Results showed that SB and JNKi recover the morphological changes induced by H 2 O 2 (Fig. 4D) . Figure 3 . Inhibitory effects of minocycline on JNK, p38 and caspase 3 activation induced by H 2 O 2 . B10BR cells were pretreated with minocycline (10, 50, 100 μM) for 1 h, followed by H 2 O 2 (250 μM) treatment for 20 min: phosphor-p38 (p-p38) was detected by Western blot analysis and quantified in A; phosphor-JNK (p-JNK) was detected by Western blot analysis and quantified in C. B10BR cells were pretreated with p38 inhibitor SB203580 (SB, 10 μM) or JNK inhibitor JNKi (10 μM) for 1 h, followed by H 2 O 2 (250 μM) treatment for 20 min: p-p38 was detected by Western blot analysis and quantified in B; p-JNK was detected by Western blot analysis and quantified in D. B10BR cells were pretreated with minocycline (10, 50, 100 μM, shown in E) or pretreated with SB and JNKi (10 μM, shown in F) for 1 h, followed by H 2 O 2 (250 μM) treatment for 12 h. Cleaved-caspase 3 was detected by Western blot analysis and quantified and normalized to ß-actin. * P<0.05 vs. control group for B10BR cells. # P<0.05 vs. H 2 O 2 (250 μM) group for B10BR cells. Data are presented as the mean ± SEM for three independent experiments. treatment and the decrease is in an H 2 O 2 concentrationdependent manner. Pretreatment with minocycline reverses H 2 O 2 effect. Similar results were seen in melanocytes pretreated with SB and JNKi (Fig. 5) .
Minocycline protects against H 2 O 2 induced apoptosis in

Discussion
Previous studies have shown that H 2 O 2 -mediated oxidative stress plays a key role in the onset as well as in the progression of vitiligo (3) . Both the epidermis and the vascular system in patients with active vitiligo are characterized by constant accumulation of H 2 O 2 , leading to impaired redox state and cell signal cascade (8, 10, 25, 26 (26) . Also H 2 O 2 was reported to mediate oxidation of epidermal ACTH, α-MSH, and ß-endorphin in vitiligo, and oxidized endorphin loses its function in the promotion of pigmentation in melanocytes (10) . Furthermore, H 2 O 2 -mediated oxidation affects calcium binding in calmodulin, leading to perturbed calcium homeostasis and perturbed l-phenylalanine-uptake in the epidermis in acute vitiligo (28) . However, the signal cascade by which H 2 O 2 induces apoptosis in melanocytes has not been well elucidated. While studies on neurodegenerative disorders have indicated that H 2 O 2 activates p38 MAPK and JNK which account for neuron loss (29, 30) and neurotoxicity (31) , the question whether they are involved in H 2 O 2 -induced melanocyte apoptosis remains unknown. Our results demonstrate that H 2 O 2 does activate p38 MAPK and JNK, but not ERK (data not shown) and also activates caspase 3. Using specific kinase inhibitors, our study further supports the notion that p38 and JNK are the most important kinases involved in H 2 O 2 -induced cell death in melanocytes, suggesting that p38 and JNK inhibitors may be developed to treat vitiligo.
Minocycline exerts protective effects on neurons. Minocycline treatment significantly reduces pro-nerve growth factor production in microglia by inhibiting phosphorylation of p38 and alleviates oligodendrocyte death (32) . Also, minocycline inhibits JNK1/2 and ERK1/2 activation and exerts antiinflammatory properties in the central nervous system (33) . Moreover, minocycline inhibits both caspase-dependent and -independent apoptotic pathways and possesses neuroprotective effects against hippocampal damage (34, 35) . We hypothesized that minocycline can inhibit H 2 O 2 -induced p38 and JNK activation and exert protective effects on melanocytes. Our results showed that minocycline inhibits p38 and JNK activation and caspase 3 activation. Inhibition of p38 and JNK activation is involved, at least in part, in the protective effect of minocycline in melanocytes, against H 2 O 2 -induced apoptosis. Our data suggest that minocycline may be useful for vitiligo therapy by preventing melanocyte loss.
In the present study, we showed that minocycline pretreatment inhibited apoptosis induced by H 2 O 2 in melanocytes. Our study suggests that minocycline may be a promising drug in preventing the loss of melanocytes and promoting repigmentation in vitiligo patients. Moreover, we found that pretreatment with minocycline reverses melanin synthesis impaired by H 2 O 2 . We propose that minocycline has no direct effects on melanin synthesis or tyrosinase activity (data not shown), and the up-regulated melanin synthesis by minocycline is most likely a consequence of an increase of melanocyte viability. Collective data from clinical application have revealed that skin pigmentation occurs in some rheumatoid patients with chronic minocycline administration (36, 37) . Although the underlying mechanism has not yet been elucidated, it has been observed that minocyclineinduced pigment deposit in papillary dermis but not in epidermis has been observed (38, 39) . Given the above, minocycline may be effective in promoting repigmentation in vitiligo patients. Further study will be carried out focusing on the protective effects of minocycline in vivo in vitiligo patients.
In conclusion, our data have shown that pretreatment with minocycline inhibited H 2 O 2 -induced p38 and JNK phosphorylation and attenuated cell death in melanocytes. This study provides insights into the understanding of the molecular mechanism of the beneficial effect of minocycline in treatment of vitiligo patients.
